Abstract PS5-03-08: Effectiveness of sacituzumab govitecan in later-line treatment of mTNBC: real-world evidence from Poland, Czech Republic, and Slovakia according to prior first-line pembrolizumab use
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: J. Żubrowska, M. Kubeczko, M. Pieniążek, A. Polakiewicz-Gilowska, M. Malejčíková, A. Konieczna, M. Holánek, I. Kolářová, R. Soumarová, H. Študentová, A. Młodzińska, K. Winsko-Szczęsnowicz, M. Lisik-Habib, A. Pękala, D. Krejčí, J. Šustr, I. Danielewicz, M. Szymanik-Resko, T. Ciszewski, L. Rusinova, A. Rudzińska, B. Czartoryska-Arłukowicz, A. Łacko, M. Jarząb, R. Pacholczak-Madej, Z. Bielčiková, M. Püsküllüoğlu
Institutions: The Maria Sklodowska-Curie National Research Institute of Oncology, Wroclaw Medical University, Národný Onkologický Ústav, Masaryk University, Masaryk Memorial Cancer Institute, Charles University, University Hospital Hradec Králové, University Hospital Kralovske Vinohrady, University Hospital Olomouc, Palacký University Olomouc, Fakultní nemocnice Bulovka, University Hospital Plzen, Medical University of Lublin, Štefan Kukura Hospital in Michalovce, General University Hospital in Prague
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7130723918
Cites:
Cited by:
Related to: